Valuation: Philadelphia Pharmaceuticals Company

Market Cap 14.92M 21.06M 18.5M 17.27M 15.85M 29.67M 2.02B 30.4M 205M 80.09M 998M 79.06M 77.34M 3.45B P/E 2024
13.7x
P/E 2025 11.9x
Enterprise Value 14.86M 20.96M 18.42M 17.19M 15.78M 29.54M 2.01B 30.26M 204M 79.73M 994M 78.7M 76.99M 3.43B EV / Sales 2024
1.32x
EV / Sales 2025 1.3x
Free-Float
7.27%
Yield 2024
4.67%
Yield 2025 -
1 day-0.50%
1 week-0.50%
Current month+19.16%
1 month+19.16%
3 months+28.39%
6 months+25.95%
Current year+24.38%
1 week 1.99
Extreme 1.99
1.99
1 month 1.71
Extreme 1.71
2.01
Current year 1.5
Extreme 1.5
2.01
1 year 1.46
Extreme 1.46
2.01
3 years 1.35
Extreme 1.35
2.01
5 years 1.28
Extreme 1.28
2.01
10 years 1.28
Extreme 1.28
3.42
Manager TitleAgeSince
Chief Executive Officer 44 01/01/2013
Chief Tech/Sci/R&D Officer - -
Director of Finance/CFO 50 01/01/2002
Director TitleAgeSince
Chairman 58 -
Director/Board Member 61 01/09/2016
Director/Board Member 64 01/01/2013
Change 5-day change 1-year change 3-year change Capi.($)
-0.50%-0.50%+35.37%+47.41% 21.06M
+0.56%+2.41%+15.42%+75.01% 49.85B
-1.74%+3.57%+56.23%+116.36% 36.89B
-0.54%+5.27%-5.96%+24.80% 12.43B
-0.68%+0.12%+12.05%+76.37% 11.69B
+1.05%+0.96%+31.25%+132.30% 9.04B
-1.36%+2.46%+47.46%-5.54% 7.15B
+0.17%+0.60%+13.68%+31.98% 6.7B
-3.16%-0.67%+1.70%+178.01% 6.66B
+0.61%-3.87%-35.09%-1.66% 5.45B
Average -0.56%+1.83%+17.21%+67.50% 14.59B
Weighted average by Cap. -0.46%+2.51%+23.61%+80.77%

Financials

2024 2025
Net sales 8.76M 12.36M 10.86M 10.14M 9.31M 17.42M 1.18B 17.85M 120M 47.02M 586M 46.41M 45.41M 2.03B 9.17M 12.94M 11.37M 10.61M 9.74M 18.23M 1.24B 18.68M 126M 49.2M 613M 48.57M 47.51M 2.12B
Net income 822K 1.16M 1.02M 951K 872K 1.63M 111M 1.67M 11.27M 4.41M 54.94M 4.35M 4.26M 190M 1.01M 1.42M 1.25M 1.16M 1.07M 2M 136M 2.05M 13.79M 5.39M 67.22M 5.32M 5.21M 232M
Net Debt 334K 471K 414K 386K 354K 663K 45.08M 680K 4.58M 1.79M 22.31M 1.77M 1.73M 77.12M -67.69K -95.49K -83.91K -78.32K -71.88K -135K -9.15M -138K -929K -363K -4.53M -359K -351K -15.65M
Logo Philadelphia Pharmaceuticals Company
Philadelphia Pharmaceuticals Industry Company PSC is a Jordan-based company that is engaged in the development, manufacture and marketing of human pharmaceutical products of different therapeutic categories. The Company, through its production facilities and laboratories located in Amman Industrial state, develops and produces a number of products that includes: Semisolid Dosage Forms, such as creams, ointments, lotions, gels and suppositories, as well as Liquid Dosage Forms, which include syrups, suspensions, solutions, nasal, drops, mouth washes and vaginal douches. Furthermore, the Company undertakes the distribution and marketing of a range of healthcare systems, miscellaneous and pharmaceuticals of different international brand names, including alimentary, gastrointestinal systems and respiratory systems. The Company markets its products to the local markets and exports to more than 10 countries in the Middle East and North Africa region.
Employees
129
Date Price Change Volume
27/07/26 JOD 1.990 -0.50% 57
22/07/26 JOD 2.000 -0.50% 800
  1. Stock Market
  2. Stocks
  3. PHIL Stock